Events & News

We are so happy to get back out on the road! Although some conferences and events remain virtual, more and more are opening up and we are running back with open arms! We hope to see you soon!

Please see below for our events and news

Schedule 1:1 Virtual Meeting

GET IN TOUCH WITH US FOR THE NEXT EVENT

Events


2023 NACHC P&I – Washington, DC

March 8-11, 2023


2023 340B Winter Coalition – San Diego, CA

March 27-29, 2023


2023 340B Summer Coalition – Washington, DC

July 10-12, 2023


2023 NACHC CHI – San Diego, CA

August 27-29, 2023


News


Rite Aid is now allowing ESP claim submission

In response to drug manufacturers policies that require Covered Entities to submit claims to 340B ESP related to their existing 340B Pharmacy Services Agreement, Rite Aid now grants limited data to be shared to 340B ESP and limited to active contract pharmacy arrangements provided that the Covered Entity adheres to the parameters and guidelines set.

READ  MORE

Rite Aid Is Now Allowing ESP Claim Submission


In response to drug manufacturers policies that require Covered Entities to submit claims to 340B ESP related to their existing 340B Pharmacy Services Agreement, Rite Aid now grants limited data to be shared to 340B ESP and limited to active contract pharmacy arrangements provided that the Covered Entity adheres to the parameters and guidelines set.

Rite Aid agreed that the following data fields can be shared to 340B ESP provided that the elements asterisked below are appropriately de-identified pursuant to 45 CFR § 164.514 prior to submission or usage by 340B ESP. The required de-identified Data Fields are Date of Service, Date Prescribed, and RX Number.

 

APPROVED DATA FIELDS:

  • Contracted Entity ID
  • Date of Service* -De-Identified
  • Date Prescribed* -De-Identified
  • NDC
  • Prescriber ID (NPI or DEA)
  • Prescriber ID Qualifier (“01” for NPI or “12” for DEA)
  • Quantity
  • Rx Number* -De-Identified
  • Service Provider ID (Pharmacy NPI or DEA)
  • Service Provider ID (“01” for NPI or “12” for DEA)
  • Wholesaler Invoice Number
  • Pharmacy NPI


340B Registration period is here! July 1st – 15th

Registration with OPAIS occurs four times a year between the first and 15th days of January, April, July and October, for both covered entities and contract pharmacies. Once registered and approved, an entity will be recognized as being active the first day of the following quarter.


OptumRx Requiring Consent to Share 340B Claims Data

According to a May 26 email to entities, pharmacy care services company OptumRx is requiring 340B covered entities to get consent before sharing OptumRx contract pharmacy claims data with drug manufacturers to satisfy manufacturers’ conditions on 340B pricing. 

READ  MORE

OptumRx Requiring Consent to Share 340B Claims Data


According to a May 26 email to entities, pharmacy care services company OptumRx is requiring 340B covered entities to get consent before sharing OptumRx contract pharmacy claims data with drug manufacturers to satisfy manufacturers’ conditions on 340B pricing. The federal government told eight of the 16 companies who put conditions on 340B pricing that their policies are illegal. While seven drug manufacturers are suing to have the government’s decisions struck down, covered entities spending more and earning less due to the companies’ denials of 340B pricing are weighing whether to give in and supply the claims data. 340B provider groups told the government that providing claims data to a drug manufacturer or drug manufacturer third-party vendor will compromise patient privacy and puts their members at legal risk. To read more click here.


AstraZeneca Pricing Issues

In early April, 340Basics noticed a significant increase in issues with AstraZeneca drug pricing, seeing that AstraZeneca pushed a bad file to wholesalers to update their systems regarding pricing restrictions for our accounts.

READ  MORE

AstraZeneca Pricing Issues


In early April, 340Basics noticed a significant increase in issues with AstraZeneca drug pricing, seeing that AstraZeneca pushed a bad file to wholesalers to update their systems regarding pricing restrictions for our accounts. This caused accounts with exceptions to be blocked and sent to us at retail pricing instead of 340B pricing. The file was likely sent from AstraZeneca to wholesalers at the end of March/beginning of April. Price files for our accounts were incorrect as of 4/2, but wholesalers are indicating that the pricing is reflecting correctly on their end, likely meaning AstraZeneca corrected the errors with an updated file sent to wholesalers after 4/2. 340Basics has not seen all accounts updated with new files to confirm and are working to request updates on affected accounts ASAP. If you have an account affected by this and wish to ensure new files are received, please contact us here: https://340basics.com/contact-us/


Gilead Announces 340B Contract Pharmacy Restrictions

Gilead recently imposed conditions on 340B pricing on its branded hepatitis C treatments when covered entities use contract pharmacies.  Click below to read more on this policy.

READ  MORE

Gilead Announces 340B Contract Pharmacy Restrictions

Gilead recently imposed conditions on 340B pricing on its branded hepatitis C treatments when covered entities use contract pharmacies. The policy, which applies to hospital and grantee entities, comes in the same week that entities became aware of an apparent change in Gilead’s HIV drug reimbursement practices, giving contract pharmacies second thoughts on whether they want to continue to partner with 340B providers. Hospitals and grantees reported receiving a March 15 letter by email stating that starting May 2, 340B covered entities must provide claims level data for Gilead’s branded hepatitis C products to remain eligible for bill to/ship to orders for multiple contract pharmacies.


340B Registration period is here! April 1st – 15th

Registration with OPAIS occurs four times a year between the first and 15th days of January, April, July and October, for both covered entities and contract pharmacies. Once registered and approved, an entity will be recognized as being active the first day of the following quarter.


Watch the recording of our Webinar: 2021: A Defining Year for 340B – What Developed, Actions Taken and What’s to Come


340Basics releases cutting-edge reporting tool inside their 340B Applications

October 2021

Managing a 340B Program can prove to be difficult, with an abundance of data and information to analyze, 340Basics has taken the guess work out of it…learn more


340Basics is awarded the 2021 GHP – Best Healthcare Software Solution in US

July 2021

We are humbled and exited to accept this global award recognizing our drive and dedication to create the best technology solution in the market…


340Basics hosted joint 340B advocacy webinar with powerful 340B players

May 2021

Hear from those “on the ground” to hear what’s next for New York and to learn how you too can fight back against such proposals if a “carve out” is proposed in your state. Watch Webinar Here.

This past year, Covered Entities participating in the 340B program in New York state fought against the state’s efforts to “carve out” the pharmacy benefit, moving it from managed care to fee-for-service. That action would have decimated the 340B program for safety net providers and vulnerable populations they serve. RWC-340B worked closely with Save New York’s Safety Net (SNYSN) in a coordinated campaign that eventually achieved a two year delay in the proposed policy.

Hear from those “on the ground” to hear what’s next for New York and to learn how you too can fight back against such proposals if a “carve out” is proposed in your state.

Speakers Include:

  • Mark Malahosky, Trillium Health/RWC-340B
  • Mike Lee, Evergreen/RWC-340B
  • Kimberleigh Smith, Callen-Lorde/Save New York’s Safety Net
  • Peggy Tighe, Powers Law Firm/RWC-340B/CV340B
  • Colleen DiClaudio (CV340B Board member/340Basics) serving as moderator

Share your concerns,

we’ll deliver solutions.

Industry-Leading 340B Software Solutions
Covered Entity & Pharmacy Expertise
Exceptional 340B Education & Support

Contact our team today.